HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Cardiomyopathies
Cardiomyopathies
Cardiomyopathies are a group of diseases that affect the heart muscle, leading to impaired heart function and, in severe cases, heart failure. These conditions can be caused by genetic factors, infections, or long-term health conditions such as hypertension. Cardiomyopathies are categorized into several types, including dilated, hypertrophic, and restrictive, each with distinct causes and symptoms. Early diagnosis and management are critical for improving the prognosis, and treatments may include medications, lifestyle changes, and in some cases, surgical interventions like heart transplants. With ongoing advancements in cardiology, there are now more options than ever for managing cardiomyopathies and helping patients lead healthy lives.
Committee Members
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain